Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

计划入组 173 人 · 首次发布于 2012 年 8 月 10 日

Laparoscopic Kasai Has Similar Anesthetic Outcomes to Open Kasai

计划入组 28 人 · 首次发布于 2023 年 12 月 8 日

Robot-assisted Modified Kasai Portoenterostomy Versus Open Kasai Portoenterostomy for Biliary Atresia

计划入组 60 人 · 首次发布于 2024 年 1 月 23 日

Kava

C₁₄H₁₆O₃

PASA-16

Kava Extract

DAIICHI SANKYO COMPANY, LIMITED

Japan

Casa Minerals Inc

United States

KALA PHARMACEUTICALS INC

United States

Breakthrough Tuberculosis Drug Targets and Novel Therapeutic Strategies Show Promise Against Drug-Resistant Strains

Ipsen's Phase III BOLD Trial of Bylvay in Biliary Atresia Misses Primary Endpoint

WHO Launches Global Platform to Accelerate Tuberculosis Treatment Trials